Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lung Cancer |
📓
Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit. Scientific reports (Sci Rep ) Vol: 13 Issue 1 Pages: 2007 Pub: 2023 Feb 3 Epub: 2023 Feb 3 Authors Haberman Y , Kamer I , Amir A , Goldenberg S , Efroni G , Daniel-Meshulam I , Lobachov A , Daher S , Hadar R , Gantz-Sorotsky H , Urban D , Braun T , Bar J , Publication |
| Lung Cancer |
📓
Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer. International journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys ) Vol: 115 Issue 2 Pages: 407-418 Pub: 2023 Feb 1 Epub: 2022 Jul 26 Authors Qiu B , Xi Y , Liu F , Li Y , Xie X , Guo J , Guo S , Wu Y , Wu L , Liang T , Ding Y , Zhang J , Wu Q , Liu H , Publication |
| Lung Cancer |
📓
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients. Cancers (Cancers (Basel) ) Vol: 14 Issue 24 Pages: Pub: 2022 Dec 19 Epub: 2022 Dec 19 Authors Grenda A , Iwan E , Krawczyk P , Frak M , Chmielewska I , Bomba A , Giza A , Rolska-Kopinska A , Szczyrek M , Kieszko R , Kucharczyk T , Jarosz B , Wasyl D , Milanowski J , Publication |
| Lung Cancer |
📓
Impact of Gut Dysbiosis on the Risk of Non-Small-Cell Lung Cancer. International journal of environmental research and public health (Int J Environ Res Public Health ) Vol: 19 Issue 23 Pages: Pub: 2022 Nov 30 Epub: 2022 Nov 30 Authors Wei YF , Huang MS , Huang CH , Yeh YT , Hung CH , Publication |
| Lung Cancer |
📓
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis. Cancers (Cancers (Basel) ) Vol: 14 Issue 21 Pages: Pub: 2022 Nov 2 Epub: 2022 Nov 2 Authors Hakozaki T , Nolin-Lapalme A , Kogawa M , Okuma Y , Nakamura S , Moreau-Amaru D , Tamura T , Hosomi Y , Takeyama H , Richard C , Hosokawa M , Routy B , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
